NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder treatments, has scheduled its fiscal third quarter 2025 earnings release and conference call. The company will announce financial results for the quarter ended June 30, 2025, before market open on August 14, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern Time to discuss quarterly results and provide a corporate update. The call will include a Q&A session for telephone participants, with replay access available until August 28, 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), un'azienda di tecnologia medica specializzata nei trattamenti per i disturbi neurologici, ha programmato la pubblicazione dei risultati finanziari del terzo trimestre fiscale 2025 e una conference call. La società annuncerà i risultati relativi al trimestre terminato il 30 giugno 2025, prima dell'apertura dei mercati, il 14 agosto 2025.
La direzione terrà una conference call e una trasmissione web per gli investitori alle 8:30 a.m. ora Eastern per discutere i risultati trimestrali e fornire un aggiornamento aziendale. La chiamata includerà una sessione di domande e risposte per i partecipanti telefonici, con la possibilità di riascoltare la registrazione fino al 28 agosto 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), una empresa de tecnología médica especializada en tratamientos para trastornos neurológicos, ha programado la publicación de sus resultados financieros del tercer trimestre fiscal de 2025 y una conferencia telefónica. La compañía anunciará los resultados correspondientes al trimestre finalizado el 30 de junio de 2025, antes de la apertura del mercado, el 14 de agosto de 2025.
La dirección realizará una llamada y webcast para inversores a las 8:30 a.m. hora del Este para discutir los resultados trimestrales y ofrecer una actualización corporativa. La llamada incluirá una sesión de preguntas y respuestas para los participantes telefónicos, con acceso a la repetición disponible hasta el 28 de agosto de 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC)는 신경 장애 치료에 특화된 의료 기술 회사로, 2025 회계연도 3분기 실적 발표 및 컨퍼런스 콜 일정을 잡았습니다. 회사는 2025년 6월 30일 종료된 분기의 재무 결과를 2025년 8월 14일 장 개장 전에 발표할 예정입니다.
경영진은 분기 실적 및 기업 업데이트를 논의하기 위해 동부 표준시 오전 8시 30분에 투자자 대상 컨퍼런스 콜 및 웹캐스트를 진행할 예정입니다. 전화 참가자를 위한 질의응답 세션이 포함되며, 녹음 재청취는 2025년 8월 28일까지 가능합니다.
NeuroOne Medical Technologies (NASDAQ: NMTC), une société de technologie médicale spécialisée dans le traitement des troubles neurologiques, a programmé la publication de ses résultats du troisième trimestre fiscal 2025 ainsi qu'une conférence téléphonique. La société annoncera les résultats financiers pour le trimestre clos le 30 juin 2025, avant l'ouverture des marchés, le 14 août 2025.
La direction tiendra une conférence téléphonique et une webdiffusion à 8h30, heure de l'Est pour discuter des résultats trimestriels et fournir une mise à jour de l'entreprise. Un temps de questions-réponses sera proposé aux participants par téléphone, avec un accès à la rediffusion disponible jusqu'au 28 août 2025.
NeuroOne Medical Technologies (NASDAQ: NMTC), ein Medizintechnikunternehmen, das sich auf die Behandlung neurologischer Erkrankungen spezialisiert hat, hat die Veröffentlichung der Ergebnisse für das dritte Geschäftsquartal 2025 und eine Telefonkonferenz angekündigt. Das Unternehmen wird die Finanzergebnisse für das Quartal zum 30. Juni 2025 vor Börsenbeginn am 14. August 2025 bekannt geben.
Das Management wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und Webcast für Investoren abhalten, um die Quartalsergebnisse zu besprechen und ein Unternehmensupdate zu geben. Die Telefonkonferenz beinhaltet eine Fragerunde für die Teilnehmer, und eine Aufzeichnung ist bis zum 28. August 2025 verfügbar.
- None.
- None.
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, May 14, 2025, to discuss the Company’s third quarter fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Third Quarter 2025 Earnings Conference Call
Date: Thursday, August 14, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 939482
Webcast: 3Q Webcast Link
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Thursday, August 28, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 52598. A webcast replay will also be available using the webcast link above through August 28, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
FAQ
When will NeuroOne (NASDAQ: NMTC) report Q3 2025 earnings?
How can investors access NeuroOne's Q3 2025 earnings call?
Until when will NeuroOne's Q3 2025 earnings call replay be available?
What is NeuroOne's main business focus?
